BioAdaptives (OTCMKTS: BDPT) announced the commercial launch of MyndMed(TM), a next-generation dietary supplement designed to enhance memory, focus, and overall brain performance. Following extensive testing with highly positive user feedback, the company is scaling production and expanding distribution to meet anticipated high demand beginning in November. Formulated to support cognitive function across short-, mid-, and long-term pathways, MyndMed(TM) delivers what the company calls “Mental Armor for Modern Minds(TM)” through clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. Manufactured in the U.S. in cGMP-certified facilities and third-party tested for purity, MyndMed(TM) is available nationwide at www.MyndMed.com.
To view the full press release, visit https://ibn.fm/2isuA
About BioAdaptives, Inc.
BioAdaptives, Inc. develops and markets science-based natural health and wellness products for both humans and animals. Its formulations leverage cutting-edge research in stem cell biology, adaptogens, and regenerative nutrition. The company’s mission is to enhance the quality of life through innovation that works in harmony with the body’s natural processes.
For more information, please visit our website at www.bioadaptives.com.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
